Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

11. Johnson P N, Chang E, Cormack E, Hornaday K, Neely S, Ranallo C, Chaaban H, Garcia-Contreras L, Miller J L. Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. The Annals of pharmacotherapy. 2024 : 10600280241282433

12. Flanagan T, Mercer K, Johnson P N, Miller J L, Yousaf F S, Perrine J. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. Journal of pharmacy practice. 2024; 37 : 985-994

13. Zelnicek T D, Miller J L, Vijayarajah S, Johnson P N. A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease. Hospital Pharmacy. 2024; 59 : 544-551

14. Johnson P N, Parman A, Miller J L. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024; 81 : e137-e140

15. Casten M, Miller J L, Neely S, Harkin M, Johnson P N. Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024; 81 : 153-158

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

6. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.


7. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


9. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.


10. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More